BioCentury | Oct 26, 2020
Emerging Company Profile

Serial dealmaker Glick to lead cancer start-up Scorpion with familiar VCs supplying $108M

...CEO, with $108 million in series A funding.Scorpion Therapeutics Inc....
...Transmembrane protein 173 Paul Bonanos IFM Therapeutics Inc. IFM Therapeutics LLC Scorpion Therapeutics Inc. precision...
Items per page:
1 - 1 of 1
BioCentury | Oct 26, 2020
Emerging Company Profile

Serial dealmaker Glick to lead cancer start-up Scorpion with familiar VCs supplying $108M

...CEO, with $108 million in series A funding.Scorpion Therapeutics Inc....
...Transmembrane protein 173 Paul Bonanos IFM Therapeutics Inc. IFM Therapeutics LLC Scorpion Therapeutics Inc. precision...
Items per page:
1 - 1 of 1